Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 5, 2013, Pages 485-491

  Nylund, Cade M ^a   Goudie, Anthony ^b   Garza, Jose M ^c   Crouch, Gary ^a   Denson, Lee A ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Pediatric inflammatory bowel disease; Pediatric thrombosis; Venous thrombosis

Indexed keywords

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGE; ARTICLE; BUDD CHIARI SYNDROME; CENTRAL VENOUS CATHETER; CEREBRAL SINUS THROMBOSIS; CHILD; COHORT ANALYSIS; CROHN DISEASE; DEEP VEIN THROMBOSIS; ENTERITIS; FEMALE; HOSPITALIZATION; HOSPITALIZED ADOLESCENT; HOSPITALIZED CHILD; HUMAN; HYPERCOAGULABILITY; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION; PORTAL VEIN THROMBOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; THROMBOPHLEBITIS; ULCERATIVE COLITIS; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADOLESCENT; AGE FACTORS; BLOOD COAGULATION DISORDERS; BUDD-CHIARI SYNDROME; CENTRAL VENOUS CATHETERS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; PARENTERAL NUTRITION; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; THROMBOPHLEBITIS; THROMBOSIS; UNITED STATES;

EID: 84877046900     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182801e43     Document Type: Article

References (51)

1. Abramson O, Durant M, Mow W, et al. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr 2006;157:233-9
2. MiehslerW, ReinischW, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004;53:542-8
3. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost 2001;85:430-4
4. Zitomersky NL, Verhave M, Trenor CC 3rd. Thrombosis and inflammatory bowel disease: A call for improved awareness and prevention. Inflamm Bowel Dis 2011;17:458-70
5. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133: 887S-968S.
6. Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: A population-based nationwide study. Gut 2011;60:937-43
7. Introduction to the HCUP KIDS' Inpatient Database (KID), 2009. http://www.hcup-us.ahrq.gov/kidoverview.jsp. Accessed June 8, 2012
8. Novacek G,Weltermann A, Sobala A, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010;139:779-87, 787.e1
9. Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004;99:97-101
10. Lazzerini M, Bramuzzo M, Maschio M, et al. Thromboembolism in pediatric inflammatory bowel disease: Systematic review. Inflamm Bowel Dis 2011;17:2174-83
11. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 1998;158:585-93
12. Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: Data from the National Hospital Discharge Survey. J Pediatr 2004;145:563-5
13. Raffini L, Huang YS, Witmer C, et al. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009;124:1001-8
14. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 1989;2:1057-62
15. Chande N, McDonald JW, Macdonald JK, et al. Unfractionated or lowmolecular weight heparin for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2010;(10):CD006774
16. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: Role of platelets. Gut 1993;34:247-51
17. Bjerregaard LT, Nederby NJ, Fredholm L, et al. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol 2002;37:62-7
18. Nakano E, Taylor CJ, Chada L, et al. Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003; 37:586-90
19. Oldenburg B, Van Tuyl BA, van der Griend R, et al. Risk factors for thromboembolic complications in inflammatory bowel disease: The role of hyperhomocysteinaemia. Dig Dis Sci 2005;50:235-40
20. Chiarantini E, Valanzano R, Liotta AA, et al. Hemostatic abnormalities in inflammatory bowel disease. Thromb Res 1996;82:137-46
21. Gris JC, Schved JF, Raffanel C, et al. Impaired fibrinolytic capacity in patients with inflammatory bowel disease. Thromb Haemost 1990; 63:472-5
22. Saibeni S, Bottasso B, Spina L, et al. Assessment of thrombin-Activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol 2004;99:1966-70
23. Koutroubakis IE. Role of thrombotic vascular risk factors in inflammatory bowel disease. Dig Dis 2000;18:161-7
24. Koutroubakis IE, Petinaki E, Anagnostopoulou E, et al. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci 1998;43:2507-12
25. Heneghan MA, Cleary B, Murray M, et al. Activated protein C resistance, thrombophilia, and inflammatory bowel disease. Dig Dis Sci 1998;43:1356-61
26. Chamouard P, Grunebaum L, Wiesel ML, et al. Prothrombin fragment 1/2 and thrombin-Antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 1995;7:1183-8
27. Talbot RW, Heppell J, Dozois R, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-5
28. Lake AM, Stauffer JQ, Stuart MJ. Hemostatic alterations in inflammatory bowel disease: Response to therapy. Am J Dig Dis 1978;23:897-902
29. Mahmood A, Needham J, Prosser J, et al. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2005;17:739-44
30. Souto JC, Martinez E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995;40:1883-9
31. Jorens PG, Hermans CR, Haber I, et al. Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis. Blut 1990;61:307-10
32. Larsen TB, Nielsen JN, Fredholm L, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb 2002;32:92-6
33. Koutroubakis IE, Sfiridaki A, Mouzas IA, et al. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2000;95:190-4
34. Saibeni S, Vecchi M, Valsecchi C, et al. Reduced free protein S levels in patients with inflammatory bowel disease: Prevalence, clinical relevance, and role of anti-protein S antibodies. Dig Dis Sci 2001;46:637-43
35. Faioni EM, Ferrero S, Fontana G, et al. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med 2004;32:S266-70
36. Papa A, Danese S, Grillo A, et al. Review article: Inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003;98: 1247-51
37. Koutroubakis IE, Sfiridaki A, Tsiolakidou G, et al. Genetic risk factors in patients with inflammatory bowel disease and vascular complications: Case-control study. Inflamm Bowel Dis 2007;13:410-5
38. Saibeni S, Spina L, Vecchi M. Exploring the relationships between inflammatory response and coagulation cascade in inflammatory bowel disease. Eur Rev Med Pharmacol Sci 2004;8:205-8
39. Angelberger S, Miehsler W, Novacek G. Colonic involvement does not predispose to thrombosis in IBD. Inflamm Bowel Dis 2009;15:316-7
40. Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-5
41. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009;123 (suppl 4):S11-7
42. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: Results from the Copenhagen City Heart Study. Circulation 2010;121:1896-903
43. Cosnes J. Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004;18:481-96
44. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008;103:2272-80
45. deBruyn J, Soon I, Hubbard J, et al. Rising hospitalization rates for pediatric inflammatory bowel diseases in the United States (1997-2006). J Pediatr Gastroenterol Nutr 2011;53(Suppl 1):E9
46. Jackson LM, O'Gorman PJ, O'Connell J, et al. Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden. QJM 1997;90:183-8
47. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000;47:763-6
48. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133: 381S-453S.
49. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133:770-6
50. Jackson PC, Morgan JM. Perioperative thromboprophylaxis in children: Development of a guideline for management. Paediatr Anaesth 2008; 18:478-87. 51
51. Turner D, Travis PLS, Griffiths AM, et al. Consensus for managing acute severe ulcerative colitis in children: A systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD working group of ESPGHAN. Am J Gastroenterol 2011;106:574-88